XRN

Here's the overview of Chiron Real Estate Inc. (NYSE: XRN) — formerly Global Medical REIT:

What it is

An internally managed healthcare REIT, HQ'd in Bethesda, MD, founded 2011, REIT status since 2016.
Formerly Global Medical REIT (GMRE) — rebranded to Chiron Real Estate Inc. effective Feb 23, 2026, with the ticker changing from GMRE to XRN (named after the Greek healer-centaur; there's also a 1-for-5 reverse split baked into all the numbers from Sept 2025).
Business model: net-lease acquisition of healthcare facilities, leased to physician groups and regional/national health systems. Portfolio has been medical office buildings (MOBs), surgical hospitals, and inpatient rehab facilities (IRFs).

The big strategic shift (this is the story)

New CEO Mark Decker Jr. took over mid-2025 and spent six months redefining strategy: broadening beyond medical office into seniors housing, including operating (SHOP/RIDEA) assets. Rebrand coincided with that pivot.
Q2 2026 was the proof point: acquired two luxury seniors communities in Alexandria, VA (The Landing + The Riviera, ~$249M) — its first SHOP investments, expected >7% stabilized yields and double-digit unlevered IRRs; and sold seven IRFs into a JV for $217M (7.3% cap), keeping a 15% stake and the asset-management role.
Portfolio mix now ~82% healthcare facilities (outpatient medical), 16% SHOP seniors housing, 2% JVs/other. Pipeline: $176M seniors community in North Bethesda (Pinnacle, Q4 close), Reston land for 131 seniors homes, and a ~$49M surgical hospital sale.

Latest numbers (Q2 2026, reported Aug 5)

Revenue $39.7M (+4.7% y/y, beat estimates); net income $63.3M / $4.78 per share — flattered by a $71.9M gain on the IRF sale (vs a small loss a year ago).
Cleaner metrics: FFO $0.88/share (vs $0.98) and Core FFO $1.04 (vs $1.14) — down y/y, reflecting the reinvestment drag.
Same-property cash NOI +0.8% (+1.7% ex a one-time item); outpatient portfolio 95% leased, 4.4-yr WALT, 4.6M sq ft.
Raised $100M of 6% Series C convertible perpetual preferred (convertible at $43/share), used to fund the pivot; H1 operating cash flow ($35.9M) covered dividends ($21.8M).

Stock snapshot (mid-Aug 2026)

Price ~$36, market cap ~$500M, ~13.7M shares out.
52-week range $29.05–$39.93; beta ~1.1.
Dividend ~$1.92/yr, yield ~5.2%, next ex-div Aug 20, 2026. (Some data providers show higher yields — stale/pre-split figures; the ~5% is the current run rate.)
Consensus Buy, avg price target ~$38 (10 analysts). EPS (TTM) is negative on prior-year losses, so the stock trades on FFO.

Things to watch

White Rock Medical Center (Dallas tenant) is in Chapter 11 — it intends to affirm its lease and is current on rent, but that's the main credit blemish.
Execution risk on the seniors-housing pivot: Riviera is still in lease-up (26% occupied at end of July), so the SHOP portfolio is a couple of years from stabilization.
The $43 conversion price on the preferred is a useful marker — it's ~19% above the current share price.

#long #analyst/orphan-reits

#long #analyst/orphan-reits

last updated: 2026-08-18